Formulasi Sediaan Tablet Ekstrak Sambung Nyawa (Gynurae procumbens (Lour).Merr) sebagai Kandidat Antidiabetes
Kata Kunci:
ekstrak daun sambung nyawa, formulasi tablet, uji in vitro dan in vivoAbstrak
Sambung nyawa leaf extract (Gynura procumbens (Lour.) Merr.) which have in vitro efficacious as antidiabetic that it can inhibit the enzyme α-glucosidase. This study aims to formulate a 70% ethanol extract of sambung nyawa leaves into a tablet dosage form that meets the quality parameters of physical and in vivo tests. Condensed extract of sambung nyawa leaves is formulated into 3 formulas with variations of filler: dibasic calcium phosphate (Formula I), lactose (Formula II) and microcrystalline cellulose (Formula III) by wet granulation method. Furthermore, the formula tested α-glucosidase inhibition, a formula which has the most activity tested in vivo. The results of physical evaluation of all formulas: organoleptic is green, bitter taste and distinctive smell; average weight uniformity: 510.26; 506.61 and 508.08 mg; tablet hardness: 6.2, 5.6 and 5.2%; friability: 0.14, 0.13 and 0.15%; desintegration time: 6 minutes 50 seconds, 7 minutes and 49 seconds and 7 minutes 39 seconds and inhibitory activity of α-glucosidase enzyme: 76.35, 67.13 and 78.14%. In this test, acarbose is used as a positive control with % inhibition is 88.49%. It can be concluded that physical quality tablet of all formulas are within the acceptable standard and is able to inhibit the enzyme α-glucosidase. Formula III is the most active. The results of in-vivo test on the 14th day after the administration at a dose tablet use 3x2 tablet per day can lower blood glucose levels.
Referensi
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















